Live Breaking News & Updates on Not For Release

Stay updated with breaking news from Not for release. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DSM and Firmenich confirm leadership team for proposed combined company DSM-Firmenich

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. NOT FOR GENERAL RELEASE IN THE UNITED STATES - SEE FURTHER INFORMATION BELOW. GENEVA and HEERLEN, Netherlands, June 13, 2022 /PRNewswire/ DSM and Firmenich today jointly announce the future leadership team for DSM-Firmenich, building on the previously announced intended merger of the two companies that will establish the leading creation and innovation partner in nutrition, beauty and well-being. The new company's Executive Committee will have a balanced team of talented individuals drawn from both DSM and Firmenich and representing the diversity, skillset, and ambitions of the combined company. The existing executive management teams of DSM and Firmenich will remain unchanged until the completion of the merger, which is expected ultimately in the first half ....

United States , United Kingdom , France General , South Africa , Geraldine Matchett , Gilbert Ghostine , Ilaria Resta , Patrick Niels , Sarah Reisinger , Jane Sinclair , Emmanuel Butstraen , Ivo Lansbergen , Philip Eykerman , University Of California , International Financial Reporting Standards , Operations Council , Group Or Firmenich International , Cola Company , Firmenich International , Management Committee , Exchange Commission , Mckinsey Company , Animal Health Nutrition , Securities Exchange , Procter Gamble , Firmenich Group ,

Mentice AB explores the conditions for carrying out a directed share issue of approximately SEK 60 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO "IMPORTANT INFORMATION" AT THE END OF THE PRESS RELEASE. STOCKHOLM, June 13, 2022 /PRNewswire/ Mentice AB ("Mentice" or the "Company") hereby announces intention to carry out a directed new issue of shares of approximately SEK 60 million directed to Swedish and international institutional investors (the "Directed New Share Issue"). The Directed New Share Issue will be carried out to, among other things, finance the acquisition of all assets relating to the software solution Ankyras from the Spanish company Galgo Medical S.L. (the "Acquisition") which the Company announ ....

United States , New Zealand , United Kingdom , South Africa , South Korea , Gran Malmberg , Siemens Healthineers , Gunilla Andersson , Neither The Company , Financial Services , Company Or Pareto Securities , European Union Withdrawal , Commission Delegated Directive , Company Certified Adviser , New Share , Directed New Share Issue , Pareto Securities , Sole Manager , Nasdaq First North Premier Growth Market , Directed New Share , Diagnostic Imaging , Setterwalls Advokatbyr , Cirio Advokatbyr , Nasdaq First North Premier Growth , Certified Adviser , Prospectus Regulation ,

Mentice AB completes a directed new share issue of approximately SEK 60 million which was significantly oversubscribed

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, CHINA HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO "IMPORTANT INFORMATION" AT THE END OF THE PRESS RELEASE. STOCKHOLM, June 10, 2022 /PRNewswire/ Mentice AB ("Mentice" or the "Company") has, in accordance with the intention announced in the Company's press release earlier today, carried out a directed new share issue of 800,000 shares, corresponding to approximately SEK 60 million (the "Directed New Share Issue"). The subscription price of the shares in the Directed New Share Issue amounts to SEK 75 per share through an accelerated bookbuilding procedure carried out by Pareto Securities AB ("Pareto Secu ....

United States , Hong Kong , United Kingdom , Free State , South Africa , South Korea , Gran Malmberg , Siemens Healthineers , Gunilla Andersson , Neither The Company , European Union Withdrawal , Commission Delegated Directive , Financial Services , Company Certified Adviser , New Share , Directed New Share Issue , Pareto Securities , Bure Equity , Handelsbanken Fonder , Sole Manager , Nasdaq First North Premier Growth Market , Directed New Share Issue Mentice , Diagnostic Imaging , Directed New Share , Setterwalls Advokatbyr , Cirio Advokatbyr ,